Vathany Kulasingam

5.0k total citations · 1 hit paper
95 papers, 2.9k citations indexed

About

Vathany Kulasingam is a scholar working on Molecular Biology, Infectious Diseases and Spectroscopy. According to data from OpenAlex, Vathany Kulasingam has authored 95 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 18 papers in Infectious Diseases and 16 papers in Spectroscopy. Recurrent topics in Vathany Kulasingam's work include SARS-CoV-2 and COVID-19 Research (16 papers), Advanced Proteomics Techniques and Applications (15 papers) and COVID-19 Clinical Research Studies (11 papers). Vathany Kulasingam is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (16 papers), Advanced Proteomics Techniques and Applications (15 papers) and COVID-19 Clinical Research Studies (11 papers). Vathany Kulasingam collaborates with scholars based in Canada, United States and Russia. Vathany Kulasingam's co-authors include Eleftherios P. Diamandis, Felix Leung, Maria Pavlou, Christopher R. Smith, Ihor Batruch, Victoria Higgins, Matthew Ierullo, Victor H. Ferreira, Deepali Kumar and Atul Humar and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Vathany Kulasingam

89 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

2008 592 citations Vathany Kulasingam, Eleftherios P. Diamandis profile →

Peers

Vathany Kulasingam

SPECT

ONCOL

Akinobu Hamada Japan

Daniele Morelli Italy

Martin K. Oehler Australia

Xianglin Yuan China

Wolfgang Hilbe Austria

Ángel Galindo García Spain

Markus Joerger Switzerland

Michael Fiegl Austria

Feng Wu China

Ihor Batruch Canada

Akinobu Hamada Japan

Vathany Kulasingam

1.2k ×0.9

233 ×0.4

SPECT

253 ×0.5

1.6k ×3.2

ONCOL

266 ×0.7

Citations per year, relative to Vathany Kulasingam Vathany Kulasingam (= 1×) peers Akinobu Hamada

Countries citing papers authored by Vathany Kulasingam

Since Specialization

Citations

This map shows the geographic impact of Vathany Kulasingam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vathany Kulasingam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vathany Kulasingam more than expected).

Fields of papers citing papers by Vathany Kulasingam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vathany Kulasingam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vathany Kulasingam. The network helps show where Vathany Kulasingam may publish in the future.

Co-authorship network of co-authors of Vathany Kulasingam

This figure shows the co-authorship network connecting the top 25 collaborators of Vathany Kulasingam. A scholar is included among the top collaborators of Vathany Kulasingam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vathany Kulasingam. Vathany Kulasingam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hendershot, Christian S., Hannah Wozniak, Vathany Kulasingam, et al.. (2024). Utilization of biomarkers for alcohol use in candidates for liver transplantation with alcohol-associated liver disease. Liver Transplantation. 31(6). 762–769.

Chandran, Vinod, et al.. (2024). Challenges in the Metabolomics-Based Biomarker Validation Pipeline. Metabolites. 14(4). 200–200. 15 indexed citations

Meo, Ashley Di, et al.. (2024). Evaluation of a New NT-proBNP Immunoassay on an Automated Core Laboratory System. The Journal of Applied Laboratory Medicine. 9(3). 579–585. 2 indexed citations

Higgins, Victoria, et al.. (2023). Evaluation of hemolysis, lipemia, and icterus interference with common clinical immunoassays. Clinical Chemistry and Laboratory Medicine (CCLM). 61(6). 1035–1045. 10 indexed citations

Mittal, Ankit, Victor H. Ferreira, Sagar Kothari, et al.. (2023). Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 29(11). 706.e1–706.e7. 5 indexed citations

Evans, Carol, et al.. (2022). Multi‐center evaluation of the highly sensitive Abbott ARCHITECT and Alinity thyroglobulin chemiluminescent microparticle immunoassay. Journal of Clinical Laboratory Analysis. 36(9). e24595–e24595. 2 indexed citations

Sohaei, Dorsa, Antigona Ulndreaj, Ioannis M. Zacharioudakis, et al.. (2022). Ultrasensitive assay for saliva-based SARS-CoV-2 antigen detection. Clinical Chemistry and Laboratory Medicine (CCLM). 60(5). 771–777. 8 indexed citations

Filippou, Panagiota S., Antoninus Soosaipillai, Dimitrios Korbakis, et al.. (2022). Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes. Clinical Chemistry and Laboratory Medicine (CCLM). 61(3). 464–472. 4 indexed citations

Sohaei, Dorsa, Antigona Ulndreaj, Anu Mathew, et al.. (2022). Sensitive Serology Measurements in the Saliva of Individuals with COVID-19 Symptoms Using a Multiplexed Immunoassay. The Journal of Applied Laboratory Medicine. 7(6). 1354–1365.

10.

Kimura, Muneyoshi, Victor H. Ferreira, Sagar Kothari, et al.. (2022). Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients. Transplantation and Cellular Therapy. 28(10). 706.e1–706.e10. 22 indexed citations

11.

Ulndreaj, Antigona, Davor Brinc, Mehmet Altan, et al.. (2022). Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study. Clinical Chemistry and Laboratory Medicine (CCLM). 61(1). 154–161. 2 indexed citations

12.

Hall, Victoria, Victor H. Ferreira, Heidi Wood, et al.. (2022). Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses. Nature Immunology. 23(3). 380–385. 67 indexed citations

13.

Ferreira, Victor H., Queenie Hu, Victoria Hall, et al.. (2022). Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings. Nature Communications. 13(1). 4489–4489. 18 indexed citations

14.

Higgins, Victoria, R. Augustin, Vathany Kulasingam, & Jennifer Taher. (2021). Sample stability of autoantibodies: A tool for laboratory quality initiatives. Clinical Biochemistry. 96. 43–48. 4 indexed citations

15.

Higgins, Victoria, et al.. (2021). Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course. Clinical Biochemistry. 90. 1–7. 12 indexed citations

16.

Ferreira, Victor H., Tina Marinelli, Matthew Ierullo, et al.. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 Infection Induces Greater T-Cell Responses Compared to Vaccination in Solid Organ Transplant Recipients. The Journal of Infectious Diseases. 224(11). 1849–1860. 13 indexed citations

17.

Diamandis, Eleftherios P., et al.. (2021). Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification. Molecular & Cellular Proteomics. 20. 100155–100155. 45 indexed citations

18.

Higgins, Victoria, et al.. (2021). Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation. Journal of Clinical Microbiology. 59(4). 86 indexed citations

19.

Fiala, Clare, et al.. (2020). Pitfalls in Cancer Biomarker Discovery and Validation with Emphasis on Circulating Tumor DNA. Cancer Epidemiology Biomarkers & Prevention. 29(12). 2568–2574. 34 indexed citations

20.

Fung, Angela W.S., et al.. (2019). Emerging role of clinical mass spectrometry in pathology. Journal of Clinical Pathology. 73(2). 61–69. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact